…at amikacin was the most active antibiotic (93.3%), followed by imipenem (77.9%) and piperacillin–tazobactam (77.2%). Ceftriaxone demons…
4articles mentioning drugs
4drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: amoxicillin–clavulanate ×
amoxicillin–clavulanate
This drug is selected. Its supporting articles are shown below.
Articles mentioning amoxicillin–clavulanate
4 articles · page 1 of 1imipenemCeftriaxoneamoxicillin–clavulanatepiperacillin–tazobactamamikacinAcute cholangitiscommon bile duct lithiasisgallbladder cancercholangiocarcinomapancreatic head tumours+3 more
IloprostSildenafilalprostadilBosentantadalafilMycophenolate mofetilnifedipineciprofloxacinflucloxacillinNintedanib+5 more
…ostadil in 2013 and iloprost in 2016, both initially effective. Iloprost was successfully re-administered in 2019 and 2024 but discontin…
ipilimumablevofloxacinnivolumabprednisoneipilimumab/nivolumabamoxicillin–clavulanatelevetiracetamadvanced clear-cell renal carcinomacorticosteroid therapy
…ase describes severe immune-mediated toxicity after one dose of ipilimumab (1 mg/kg) and nivolumab (3 mg/kg) in a stage IV patient who dev…
amoxicillin–clavulanatechronic lung diseaseintravenous antibiotics
… After 1–3 days of intravenous antibiotics, then 3 days of oral amoxicillin–clavulanate, they were randomised to extended (13–14 days) or standard (5–6…